Publication: COVID-19 vaccinology landscape in Africa
dc.contributor.author | Baptista, Sara | |
dc.contributor.author | Gitaka, Jesse | |
dc.contributor.author | Kano, iBernard N. | |
dc.contributor.author | Mbaebie Blessing Oyedemi | |
dc.contributor.author | Enany, Shymaa | |
dc.contributor.author | Naidoo, Sanushka | |
dc.contributor.author | Suliman, Sara | |
dc.contributor.author | Nepolo, Emmanuel | |
dc.contributor.author | Gitaka, Jesse | |
dc.date.accessioned | 2024-06-06T06:47:00Z | |
dc.date.available | 2024-06-06T06:47:00Z | |
dc.date.issued | 2022-12-05 | |
dc.description.abstract | More than two years after the start of COVID-19 pandemic, Africa still lags behind in terms vaccine distribution. This highlights the predicament of Africa in terms of vaccine development, deployment, and sustainability, not only for COVID-19, but for other major infectious diseases that plague the continent. This opinion discusses the challenges Africa faces in its race to vaccinate its people, and offers recommendations on the way forward. Specifically, to get out of the ongoing vaccine shortage trap, Africa needs to diversify investment not only to COVID-19 but also other diseases that burden the population. The continent needs to increase its capacity to acquire vaccines more equitably, improve access to technologies to enable local manufacture of vaccines, increase awareness on vaccines both in rural and urban areas to significantly reduce disease incidence of COVID-19 and as well as other prevalent diseases on the African continent such as HIV and TB. Such efforts will go a long way to reduce the disease burden in Africa. | |
dc.description.sponsorship | SS was supported by an award from the Massachusetts Life Sciences Center Accelerating Coronavirus Testing Solutions (A.C.T.S), Nina Ireland Program for Lung Health, and the Chan Zuckerberg Biohub Initiative. JG and BNK were supported by Africa Academy of Sciences funding for Covid-19 Research & Development goals for Africa (SARSCoV2-4-20-010). The funding sources had no role in study design, collection, analysis, interpretation of data, and publication. | |
dc.identifier.citation | AUTHOR=Baptista Sara , Naidoo Sanushka , Suliman Sara , Nepolo Emmanuel , Kanoi Bernard N. , Gitaka Jesse , Blessing Oyedemi Mbaebie , Enany Shymaa TITLE=COVID-19 vaccinology landscape in Africa JOURNAL=Frontiers in Immunology VOLUME=13 YEAR=2022 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.955168 DOI=10.3389/fimmu.2022.955168 ISSN=1664-3224 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | https://erepository.mku.ac.ke/handle/123456789/5835 | |
dc.language.iso | en | |
dc.publisher | Frontiers | |
dc.subject | : vaccinology | |
dc.subject | Africa | |
dc.subject | COVID - 19 | |
dc.subject | local manufacture | |
dc.subject | improved access | |
dc.subject | vaccines | |
dc.title | COVID-19 vaccinology landscape in Africa | |
dc.type | Article | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 2979b960-59ad-48e8-9c21-8fabdd9b8f60 | |
relation.isAuthorOfPublication.latestForDiscovery | 2979b960-59ad-48e8-9c21-8fabdd9b8f60 |